HIDRAT CRISTALIN AL CLORHIDRATULUI DE 6-HIDROXI-3-(4-[2-PIPERIDIN-1-IL)ETOXI]-FENOXI)-2-(4-METOXIFENIL)BENZO[b]TIOFEN, PROCEDEU DE PREPARARE ŞI COMPOZIŢII FARMACEUTICE CARE ÎL CONŢIN
Price not visible for this package
Interest:
Assignment
Publication info:
No.: RO121851
Date: 30.06.2008
Inventor(s):
BUSH JULIE KAY [US]
CONRAD PRESTON CHARLES [US]
FLOM MERLYN GERARD [US]
LUKE WAYNE DOUGLAS [US]
Applicant(s):
LILLY CO ELI [US]
Classification:
International patent classification (IPC):
A61K31/38; A61K31/4535; A61K31/566; A61K31/567; A61K31/57; A61K38/22; A61K45/00; A61K45/06; A61P15/00; A61P19/08; A61P19/10; A61P25/00; A61P25/28; A61P3/06; A61P35/00; A61P43/00; A61P5/32; A61P9/00; C07D333/62; C07D333/64; C07D409/12
Cooperative patent classification (CPC):
A61K31/4535 (EP); A61K31/567 (EP); A61K38/09 (EP); A61K45/06 (EP); A61P15/00 (EP); A61P19/08 (EP); A61P19/10 (EP); A61P25/00 (EP); A61P25/28 (EP); A61P3/00 (EP); A61P3/06 (EP); A61P35/00 (EP); A61P35/04 (EP); A61P43/00 (EP); A61P5/30 (EP); A61P5/32 (EP); A61P9/00 (EP); A61P9/10 (EP); C07D333/64 (EP); C07D409/12 (KR); A61K31/4535; A61K2300/00; A61K31/567; A61K38/09
Application info:
No.: RO20000000736
Date:
21.07.2000
Priority number(s):
US19990146286P
29.07.1999
; US19990147570P
06.08.1999
; US19990149773P
19.08.1999
Related patents:
AR031073; AT502318; AU6335600; BE1013411; BR0003209; CA2314682; CN1138770; CN1288007; CO5180570; CZ20002716; CZ299311; DE10036854; DK200001151; DZ3060; EP1204656; FI20001722; FR2796944; GB2352717; GR1004084; GR20000100265; HK1035370; HRP20000503; HU0003001; ID27078; IE20000605; IL137553; IT1318660; ITMI20001759; JP2001064277; KR100697177; KR20010049916; LT2000076; LT4790; LU90617; LV12623; MD20000162; MD2336; MXPA00007461; MY128764; NL1015821; NO20003879; PE20010385; PL341749; PT102502; SE0002792; SG91296; SI20426; SV2002000132; TR200002206; TWI276437; UA72885; WO0109116
Description:
Invenţia se referă la un nou hidrat cristalin al clorhidratului de 6-hidroxi-3-(4-[2-(piperidin-1-il)etoxi]-fenoxi)-2-(4-metoxifenil)benzo[b]tiofen(arzoxifen), la procedeul de preparare a acestuia ?i la compoziţiile farmaceutice utilizate în tratamentul stărilor maladive asociate cu lipsa de estrogen.
